Literature DB >> 30641434

Measurement of the 43Sc production cross-section with a deuteron beam.

Tommaso Stefano Carzaniga1, Nicholas P van der Meulen2, Roger Hasler3, Christian Kottler4, Peter Peier4, Andreas Türler5, Etienne Vermeulen3, Christof Vockenhuber6, Saverio Braccini7.   

Abstract

43,44Sc/47Sc is one of the most promising theranostic pairs in nuclear medicine. The co-emission of 1157 keV γ-rays with 99.9% branching ratio by 44Sc and the presence of its metastable state 44 mSc push to favour the adoption of 43Sc for Positron Emission Tomography (PET) diagnostic procedures to lighten the dose to the patient and to the personnel. The β+ emitter 43Sc can be produced at a medical cyclotron by proton bombardment of an enriched 43Ca or 46Ti oxide target. 43Sc can be also produced by deuteron bombardment of an enriched 42Ca oxide target. Only a few medical cyclotrons currently in operation offer deuteron beams. Some can be adapted to operate both a proton or a deuteron source. To compare these three production routes, an accurate knowledge of the cross-sections is essential. In this paper, we report on the cross-section measurement of the reaction 42Ca(d,n)43Sc performed at the 6 MV HVEC EN-Tandem of the Ion Beam Physics group at ETH in Zürich. A study of the production yield by using commercially available enriched target materials is also presented.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cross-section; Deuteron beams; PET radioisotopes; Positron Emission Tomography (PET); Scandium

Mesh:

Substances:

Year:  2018        PMID: 30641434     DOI: 10.1016/j.apradiso.2018.12.031

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  1 in total

Review 1.  Production of scandium radionuclides for theranostic applications: towards standardization of quality requirements.

Authors:  R Mikolajczak; S Huclier-Markai; C Alliot; F Haddad; D Szikra; V Forgacs; P Garnuszek
Journal:  EJNMMI Radiopharm Chem       Date:  2021-05-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.